Stockholm, Sweden – November 6th, 2017 – Anita Tollstadius, CEO of ContextVision, is one of five finalists among CEOs for small companies in Sweden, an award founded by management website motivation.se. There were in total 120 nominations in four different categories, and the winner will be announced on November 16th. Being one of the finalists reflects leadership and company growth as well as sustainability. ContextVision grew both in 2015 and 2016, and sustainability is strongly reflected in the present investments into research within digital pathology. The company intends to deliver new innovative products based on artificial intelligence, which will improve the accuracy of cancer diagnosis and save time. The purpose is to improve efficiency for the healthcare providers and at the same time help patients to earlier accurate treatment.
About ContextVision
ContextVision is a medical technology company specializing in image analysis and artificial intelligence. Its cutting-edge technology helps doctors accurately interpret medical images, a crucial foundation for better diagnosis and treatment. As an industry pioneer for more than 30 years, ContextVision is taking a leading position within deep learning, the latest artificial intelligence technology. ContextVision is currently investing significantly in the field to expand its product portfolio. The present product portfolio includes state-of-the-art image enhancement software for 2D/3D/4D ultrasound, MRI, X-ray and mammography which is used by leading equipment manufacturers worldwide. ContextVision is based in Sweden and listed on the Oslo Stock Exchange under the ticker COV. For more information, please visit http://www.contextvision.com.